However, both in our discovery cohort with plasma and the replication SSc cohort using sera, we observed higher levels of CXCL4 than in controls, and a significant and specific correlation between CXCL4 and IFN-α levels, strongly supporting our general conceptual framework. The gene discussed is PF4; the disease is systemic sclerosis.